US Stock MarketDetailed Quotes

URGN UroGen Pharma Ltd

Watchlist
  • 10.965
  • +0.255+2.38%
Trading Dec 20 13:08 ET
462.72MMarket Cap-3.63P/E (TTM)

UroGen Pharma Ltd Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
20.87%25.2M
3.35%21.85M
9.24%18.78M
28.52%82.71M
30.06%23.53M
29.54%20.85M
27.31%21.14M
26.75%17.19M
33.96%64.36M
11.86%18.09M
Operating revenue
20.87%25.2M
3.35%21.85M
9.24%18.78M
28.52%82.71M
30.06%23.53M
29.54%20.85M
27.31%21.14M
26.75%17.19M
33.96%64.36M
11.86%18.09M
Cost of revenue
3.63%2.45M
-8.76%2.23M
-23.71%1.73M
22.30%9.36M
1.02%2.29M
17.18%2.37M
32.34%2.44M
48.52%2.27M
48.42%7.65M
42.42%2.26M
Gross profit
23.08%22.75M
4.94%19.62M
14.24%17.05M
29.36%73.35M
34.21%21.24M
31.31%18.49M
26.68%18.7M
23.99%14.93M
32.22%56.7M
8.53%15.83M
Operating expense
25.98%40.3M
33.39%45.46M
15.74%42.79M
2.32%138.89M
-0.71%35.85M
-0.56%31.99M
1.81%34.08M
8.75%36.97M
0.42%135.74M
4.67%36.11M
Selling and administrative expenses
33.03%28.94M
33.62%30.06M
11.54%27.3M
12.60%93.27M
13.48%24.55M
14.07%21.76M
7.97%22.49M
14.90%24.47M
-5.37%82.84M
1.01%21.63M
Research and development costs
11.00%11.36M
32.96%15.4M
23.97%15.49M
-13.78%45.61M
-21.93%11.3M
-21.87%10.23M
-8.35%11.58M
-1.56%12.5M
11.05%52.91M
10.66%14.48M
Operating profit
-29.96%-17.55M
-67.98%-25.84M
-16.76%-25.74M
17.09%-65.54M
27.97%-14.61M
25.36%-13.5M
17.81%-15.38M
-0.40%-22.05M
14.36%-79.04M
-1.84%-20.28M
Net non-operating interest income expense
101.21%36K
47.71%-1.74M
77.68%-649K
-60.99%-12.07M
-3.85%-2.86M
-32.27%-2.98M
-57.56%-3.33M
-938.57%-2.91M
-3,637.74%-7.5M
-1,970.68%-2.75M
Non-operating interest income
230.18%2.76M
295.86%1.72M
178.76%1.8M
181.56%2.64M
54.80%726K
89.34%835K
239.84%435K
32,150.00%645K
156.99%938K
2,245.00%469K
Non-operating interest expense
-28.68%2.72M
-7.98%3.46M
-31.13%2.45M
74.39%14.72M
11.26%3.59M
41.61%3.82M
67.98%3.76M
1,159.93%3.55M
--8.44M
--3.22M
Other net income (expense)
-12.30%-6.07M
-7.69%-5.79M
-11.53%-5.84M
3.60%-20.71M
8.77%-4.69M
-13.09%-5.41M
7.87%-5.37M
10.14%-5.24M
-24.27%-21.49M
29.21%-5.14M
Gain on sale of security
-7.96%-5.92M
-8.03%-5.77M
-8.35%-5.66M
0.03%-21.55M
-8.34%-5.51M
-13.70%-5.48M
8.38%-5.34M
10.33%-5.22M
-24.68%-21.56M
30.80%-5.08M
Other non- operating income (expenses)
-322.54%-158K
53.33%-14K
-1,120.00%-183K
1,063.89%838K
1,388.89%812K
91.89%71K
---30K
-275.00%-15K
--72K
---63K
Income before tax
-7.74%-23.58M
-38.55%-33.37M
-6.76%-32.23M
8.98%-98.32M
21.36%-22.16M
12.87%-21.89M
9.67%-24.08M
-7.57%-30.19M
1.23%-108.03M
-3.17%-28.18M
Income tax
1,111.11%91K
-29.63%38K
157.14%54K
123.36%3.92M
459.36%3.85M
-101.27%-9K
68.75%54K
-93.54%21K
21.12%1.76M
-39.40%689K
Net income
-8.20%-23.67M
-38.39%-33.4M
-6.86%-32.29M
6.87%-102.24M
9.88%-26.02M
15.30%-21.88M
9.57%-24.14M
-6.41%-30.21M
0.94%-109.78M
-1.47%-28.87M
Net income continuous Operations
-8.20%-23.67M
-38.39%-33.4M
-6.86%-32.29M
6.87%-102.24M
9.88%-26.02M
15.30%-21.88M
9.57%-24.14M
-6.41%-30.21M
0.94%-109.78M
-1.47%-28.87M
Minority interest income
Net income attributable to the parent company
-8.20%-23.67M
-38.39%-33.4M
-6.86%-32.29M
6.87%-102.24M
9.88%-26.02M
15.30%-21.88M
9.57%-24.14M
-6.41%-30.21M
0.94%-109.78M
-1.47%-28.87M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-8.20%-23.67M
-38.39%-33.4M
-6.86%-32.29M
6.87%-102.24M
9.88%-26.02M
15.30%-21.88M
9.57%-24.14M
-6.41%-30.21M
0.94%-109.78M
-1.47%-28.87M
Basic earnings per share
19.12%-0.55
11.65%-0.91
25.38%-0.97
26.20%-3.55
45.90%-0.66
39.82%-0.68
12.71%-1.03
-4.00%-1.3
3.02%-4.81
3.94%-1.22
Diluted earnings per share
19.12%-0.55
11.65%-0.91
25.38%-0.97
26.20%-3.55
45.90%-0.66
39.82%-0.68
12.71%-1.03
-4.00%-1.3
3.02%-4.81
3.94%-1.22
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2024 (Q2)Jun 30, 2024 (Q1)Mar 31, 2024 (FY)Dec 31, 2023 (Q4)Dec 31, 2023 (Q3)Sep 30, 2023 (Q2)Jun 30, 2023 (Q1)Mar 31, 2023 (FY)Dec 31, 2022 (Q4)Dec 31, 2022
Total revenue 20.87%25.2M 3.35%21.85M 9.24%18.78M 28.52%82.71M 30.06%23.53M 29.54%20.85M 27.31%21.14M 26.75%17.19M 33.96%64.36M 11.86%18.09M
Operating revenue 20.87%25.2M 3.35%21.85M 9.24%18.78M 28.52%82.71M 30.06%23.53M 29.54%20.85M 27.31%21.14M 26.75%17.19M 33.96%64.36M 11.86%18.09M
Cost of revenue 3.63%2.45M -8.76%2.23M -23.71%1.73M 22.30%9.36M 1.02%2.29M 17.18%2.37M 32.34%2.44M 48.52%2.27M 48.42%7.65M 42.42%2.26M
Gross profit 23.08%22.75M 4.94%19.62M 14.24%17.05M 29.36%73.35M 34.21%21.24M 31.31%18.49M 26.68%18.7M 23.99%14.93M 32.22%56.7M 8.53%15.83M
Operating expense 25.98%40.3M 33.39%45.46M 15.74%42.79M 2.32%138.89M -0.71%35.85M -0.56%31.99M 1.81%34.08M 8.75%36.97M 0.42%135.74M 4.67%36.11M
Selling and administrative expenses 33.03%28.94M 33.62%30.06M 11.54%27.3M 12.60%93.27M 13.48%24.55M 14.07%21.76M 7.97%22.49M 14.90%24.47M -5.37%82.84M 1.01%21.63M
Research and development costs 11.00%11.36M 32.96%15.4M 23.97%15.49M -13.78%45.61M -21.93%11.3M -21.87%10.23M -8.35%11.58M -1.56%12.5M 11.05%52.91M 10.66%14.48M
Operating profit -29.96%-17.55M -67.98%-25.84M -16.76%-25.74M 17.09%-65.54M 27.97%-14.61M 25.36%-13.5M 17.81%-15.38M -0.40%-22.05M 14.36%-79.04M -1.84%-20.28M
Net non-operating interest income expense 101.21%36K 47.71%-1.74M 77.68%-649K -60.99%-12.07M -3.85%-2.86M -32.27%-2.98M -57.56%-3.33M -938.57%-2.91M -3,637.74%-7.5M -1,970.68%-2.75M
Non-operating interest income 230.18%2.76M 295.86%1.72M 178.76%1.8M 181.56%2.64M 54.80%726K 89.34%835K 239.84%435K 32,150.00%645K 156.99%938K 2,245.00%469K
Non-operating interest expense -28.68%2.72M -7.98%3.46M -31.13%2.45M 74.39%14.72M 11.26%3.59M 41.61%3.82M 67.98%3.76M 1,159.93%3.55M --8.44M --3.22M
Other net income (expense) -12.30%-6.07M -7.69%-5.79M -11.53%-5.84M 3.60%-20.71M 8.77%-4.69M -13.09%-5.41M 7.87%-5.37M 10.14%-5.24M -24.27%-21.49M 29.21%-5.14M
Gain on sale of security -7.96%-5.92M -8.03%-5.77M -8.35%-5.66M 0.03%-21.55M -8.34%-5.51M -13.70%-5.48M 8.38%-5.34M 10.33%-5.22M -24.68%-21.56M 30.80%-5.08M
Other non- operating income (expenses) -322.54%-158K 53.33%-14K -1,120.00%-183K 1,063.89%838K 1,388.89%812K 91.89%71K ---30K -275.00%-15K --72K ---63K
Income before tax -7.74%-23.58M -38.55%-33.37M -6.76%-32.23M 8.98%-98.32M 21.36%-22.16M 12.87%-21.89M 9.67%-24.08M -7.57%-30.19M 1.23%-108.03M -3.17%-28.18M
Income tax 1,111.11%91K -29.63%38K 157.14%54K 123.36%3.92M 459.36%3.85M -101.27%-9K 68.75%54K -93.54%21K 21.12%1.76M -39.40%689K
Net income -8.20%-23.67M -38.39%-33.4M -6.86%-32.29M 6.87%-102.24M 9.88%-26.02M 15.30%-21.88M 9.57%-24.14M -6.41%-30.21M 0.94%-109.78M -1.47%-28.87M
Net income continuous Operations -8.20%-23.67M -38.39%-33.4M -6.86%-32.29M 6.87%-102.24M 9.88%-26.02M 15.30%-21.88M 9.57%-24.14M -6.41%-30.21M 0.94%-109.78M -1.47%-28.87M
Minority interest income
Net income attributable to the parent company -8.20%-23.67M -38.39%-33.4M -6.86%-32.29M 6.87%-102.24M 9.88%-26.02M 15.30%-21.88M 9.57%-24.14M -6.41%-30.21M 0.94%-109.78M -1.47%-28.87M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -8.20%-23.67M -38.39%-33.4M -6.86%-32.29M 6.87%-102.24M 9.88%-26.02M 15.30%-21.88M 9.57%-24.14M -6.41%-30.21M 0.94%-109.78M -1.47%-28.87M
Basic earnings per share 19.12%-0.55 11.65%-0.91 25.38%-0.97 26.20%-3.55 45.90%-0.66 39.82%-0.68 12.71%-1.03 -4.00%-1.3 3.02%-4.81 3.94%-1.22
Diluted earnings per share 19.12%-0.55 11.65%-0.91 25.38%-0.97 26.20%-3.55 45.90%-0.66 39.82%-0.68 12.71%-1.03 -4.00%-1.3 3.02%-4.81 3.94%-1.22
Dividend per share
Currency Unit USD USD USD USD USD USD USD USD USD USD
Accounting Standards US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP
Audit Opinions -- -- -- Unqualified Opinion with Explanatory Notes -- -- -- -- -- --
Heat List
US
Overall
Symbol
Price
% Chg

No Data